NYSE:MMS - MAXIMUS Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$69.46 -0.49 (-0.70 %)
(As of 12/16/2018 04:00 PM ET)
Previous Close$69.46
Today's Range$68.98 - $70.19
52-Week Range$60.00 - $72.71
Volume407,569 shs
Average Volume444,229 shs
Market Capitalization$4.45 billion
P/E Ratio20.43
Dividend Yield1.44%
Beta1.03
MAXIMUS, Inc. provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews. Its services include health insurance exchange customer contact center operations and support; health insurance program eligibility and enrollment; beneficiary outreach and education; application assistance and independent health plan enrollment counseling; premium payment processing and administration; eHealth solutions; independent disability, long-term sick, and health assessments; occupational health clinical assessments; and specialized program consulting services. The company's U.S. Federal Services segment offers services, including centralized customer contact centers and support services; documents and records management; and case management, citizen engagement, and consumer education; independent medical reviews and worker's compensation benefit appeals; health benefit appeals; eligibility appeals; modernization of systems and IT infrastructure; infrastructure operations and support; software development, operations, and management; and data analytics. Its Human Services segment provides national, state, and local human services agencies with various BPS and related consulting services for welfare-to-work, child support, and higher education; and management tools and professional consulting, program consulting, and tax credit and employer services. MAXIMUS, Inc. was founded in 1975 and is headquartered in Reston, Virginia.

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
Current SymbolNYSE:MMS
Previous Symbol
CUSIP57793310
Phone703-251-8500

Debt

Debt-to-Equity RatioN/A
Current Ratio2.91
Quick Ratio2.91

Price-To-Earnings

Trailing P/E Ratio20.43
Forward P/E Ratio18.98
P/E Growth1.9

Sales & Book Value

Annual Sales$2.39 billion
Price / Sales1.86
Cash Flow$4.4554 per share
Price / Cash Flow15.59
Book Value$16.91 per share
Price / Book4.11

Profitability

EPS (Most Recent Fiscal Year)$3.40
Net Income$220.75 million
Net Margins9.23%
Return on Equity20.23%
Return on Assets14.97%

Miscellaneous

Employees18,600
Outstanding Shares64,130,000
Market Cap$4.45 billion
OptionableOptionable

MAXIMUS (NYSE:MMS) Frequently Asked Questions

What is MAXIMUS's stock symbol?

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?

MAXIMUS announced a quarterly dividend on Tuesday, October 16th. Stockholders of record on Thursday, November 15th will be given a dividend of $0.25 per share on Friday, November 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date of this dividend is Wednesday, November 14th. This is an increase from MAXIMUS's previous quarterly dividend of $0.05. View MAXIMUS's Dividend History.

How will MAXIMUS's stock buyback program work?

MAXIMUS announced that its board has initiated a share repurchase plan on Monday, June 25th 2018, which authorizes the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 4.9% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its shares are undervalued.

How were MAXIMUS's earnings last quarter?

MAXIMUS, Inc. (NYSE:MMS) announced its quarterly earnings data on Tuesday, November, 20th. The health services provider reported $0.71 earnings per share for the quarter, missing analysts' consensus estimates of $0.72 by $0.01. The health services provider earned $558.50 million during the quarter, compared to analyst estimates of $587.58 million. MAXIMUS had a net margin of 9.23% and a return on equity of 20.23%. The business's revenue was down 10.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.81 earnings per share. View MAXIMUS's Earnings History.

When is MAXIMUS's next earnings date?

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for MAXIMUS.

What guidance has MAXIMUS issued on next quarter's earnings?

MAXIMUS updated its FY 2019 earnings guidance on Tuesday, November, 20th. The company provided earnings per share guidance of $3.55-3.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.42. The company issued revenue guidance of $2.925-3 billion, compared to the consensus revenue estimate of $2.53 billion.

What price target have analysts set for MMS?

2 brokerages have issued twelve-month price targets for MAXIMUS's shares. Their predictions range from $67.00 to $81.00. On average, they expect MAXIMUS's share price to reach $72.3333 in the next twelve months. This suggests a possible upside of 4.1% from the stock's current price. View Analyst Price Targets for MAXIMUS.

What is the consensus analysts' recommendation for MAXIMUS?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

Has MAXIMUS been receiving favorable news coverage?

Headlines about MMS stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. MAXIMUS earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned news articles about the health services provider a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are some of MAXIMUS's key competitors?

Who are MAXIMUS's key executives?

MAXIMUS's management team includes the folowing people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 51)
  • Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 66)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 63)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 57)
  • Mr. Mark S. Andrekovich, Chief of Human Capital and Pres of Tax & Employer Services (Age 56)

Who are MAXIMUS's major shareholders?

MAXIMUS's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.35%), Vanguard Group Inc (10.55%), Vanguard Group Inc. (10.55%), Victory Capital Management Inc. (6.17%), Bamco Inc. NY (3.79%) and Mackenzie Financial Corp (2.45%). Company insiders that own MAXIMUS stock include Anne K Altman, Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

Which institutional investors are selling MAXIMUS stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Brown Advisory Inc., Public Employees Retirement Association of Colorado, Bamco Inc. NY, Morgan Stanley, Capital Fund Management S.A., Russell Investments Group Ltd. and BlueMountain Capital Management LLC. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Mark Andrekovich, Paul R Lederer, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

Which institutional investors are buying MAXIMUS stock?

MMS stock was bought by a variety of institutional investors in the last quarter, including Epoch Investment Partners Inc., Credit Suisse AG, Victory Capital Management Inc., Mackenzie Financial Corp, Renaissance Technologies LLC, AQR Capital Management LLC, American Century Companies Inc. and First Quadrant L P CA. View Insider Buying and Selling for MAXIMUS.

How do I buy shares of MAXIMUS?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MAXIMUS's stock price today?

One share of MMS stock can currently be purchased for approximately $69.46.

How big of a company is MAXIMUS?

MAXIMUS has a market capitalization of $4.45 billion and generates $2.39 billion in revenue each year. The health services provider earns $220.75 million in net income (profit) each year or $3.40 on an earnings per share basis. MAXIMUS employs 18,600 workers across the globe.

What is MAXIMUS's official website?

The official website for MAXIMUS is http://www.maximus.com.

How can I contact MAXIMUS?

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]


MarketBeat Community Rating for MAXIMUS (NYSE MMS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  355 (Vote Outperform)
Underperform Votes:  336 (Vote Underperform)
Total Votes:  691
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel